Search

Your search keyword '"Mogensen, Trine"' showing total 350 results

Search Constraints

Start Over You searched for: Author "Mogensen, Trine" Remove constraint Author: "Mogensen, Trine" Search Limiters Full Text Remove constraint Search Limiters: Full Text
350 results on '"Mogensen, Trine"'

Search Results

1. SARS-CoV-2 brainstem encephalitis in human inherited DBR1 deficiency.

2. TMEFF1 is a neuron-specific restriction factor for herpes simplex virus

3. Human TMEFF1 is a restriction factor for herpes simplex virus in the brain

4. Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in children

5. Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds

6. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

7. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

8. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

13. Monozygotic triplets with juvenile-onset autoimmunity and 18p microdeletion involving PTPRM.

14. Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications.

15. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio

16. Cholesterol-binding motifs in STING that control endoplasmic reticulum retention mediate anti-tumoral activity of cholesterol-lowering compounds

17. Clonal hematopoiesis and COVID-19 hospitalization in Danish adults

18. HSV‐1 ICP27 targets the TBK1‐activated STING signalsome to inhibit virus‐induced type I IFN expression

21. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis

22. Alveolar cytokines and interferon autoantibodies in COVID-19 ARDS.

23. Clonal hematopoiesis and COVID‐19 hospitalization in Danish adults.

24. An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis

25. Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants

28. Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

29. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

30. Benign recurrent lymphocytic meningitis (Mollaret's meningitis) in Denmark: a nationwide cohort study.

31. Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants

32. Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants

33. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

34. Brain immune cells undergo cGAS/STING-dependent apoptosis during herpes simplex virus type 1 infection to limit type I IFN production

38. Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children

39. Additional file 1 of Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

40. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

41. Case report:Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton’s agammaglobulinemia

42. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

43. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

45. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

47. Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

48. Local immunopathology in COVID-19 associated lung injury

49. Human genetic and immunological determinants of critical COVID-19 pneumonia

50. Studying severe long COVID to understand post-infectious disorders beyond COVID-19.

Catalog

Books, media, physical & digital resources